Visceral leishmaniasis: clinical observations in 4 US army soldiers deployed to Afghanistan or Iraq, 2002-2004.

P eople who traveled to Central or Southwest Asia in support of Operation Enduring Freedom and Operation Iraqi Freedom may have been exposed to various diseases endemic to this region. Some of these conditions have long incubation periods and may not present for weeks or months after travelers have returned to the United States. Among such diseases is visceral leishmaniasis (VL). Visceral leishmaniasis is a chronic systemic disease caused by parasites of the Leishmania donovani–Leishmania infantum complex. It is classically described as a syndrome of fever, progressive spleen and/or liver enlargement, weight loss, pancytopenia, and, if untreated, possible death. Most cases are acquired via the bite of infected female sand flies, but on rare occasions, disease has been acquired by other means, most notably by blood transfusions. This case series describes 4 cases of VL and is intended to alert clinicians to the possibility of VL in patients who develop a febrile illness after returning from deployment to Central or Southwest Asia.

[1]  F. Chappuis,et al.  A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis , 2006, BMJ : British Medical Journal.

[2]  S. Sundar,et al.  Rapid, Noninvasive Diagnosis of Visceral Leishmaniasis in India: Comparison of Two Immunochromatographic Strip Tests for Detection of Anti-K39 Antibody , 2006, Journal of Clinical Microbiology.

[3]  F. Chappuis,et al.  Diagnostic Accuracy of Two rK39 Antigen-Based Dipsticks and the Formol Gel Test for Rapid Diagnosis of Visceral Leishmaniasis in Northeastern Uganda , 2005, Journal of Clinical Microbiology.

[4]  H. Murray Treatment of visceral leishmaniasis in 2004. , 2004, The American journal of tropical medicine and hygiene.

[5]  Shyam Sundar,et al.  Laboratory Diagnosis of Visceral Leishmaniasis , 2002, Clinical and Vaccine Immunology.

[6]  M. Wallace,et al.  Endemic infectious diseases of Afghanistan. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  G. Wortmann,et al.  Rapid diagnosis of leishmaniasis by fluorogenic polymerase chain reaction. , 2001, The American journal of tropical medicine and hygiene.

[8]  A. Meyerhoff U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  A. Magill Epidemiology of the leishmaniases. , 1995, Dermatologic clinics.

[10]  S. Reed,et al.  New perspectives on a subclinical form of visceral leishmaniasis. , 1986, The Journal of infectious diseases.

[11]  R. Badaró,et al.  A prospective study of visceral leishmaniasis in an endemic area of Brazil. , 1986, The Journal of infectious diseases.

[12]  S. Pampiglione,et al.  Studies on mediterranean Leishmaniasis. I. An outbreak of visceral leishmaniasis in Northern Italy. , 1974, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[13]  S. Pampiglione,et al.  Studies on Mediterranean leishmaniasis. 2. Asymptomatic cases of visceral leishmaniasis. , 1974, Transactions of the Royal Society of Tropical Medicine and Hygiene.